BROVANA Side Effects

6689266-5 | Cerebrovascular Accident, Transient Ischaemic Attack
on Apr 05, 2010 Female patient from UNITED STATES , 73 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Brovana (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, transient ischaemic attack. Brovana dosage: 15 Ug/2ml;bid;inhalation. During the same period patient was treated with PULMICORT (View Pulmicort Review and Pulmicort Label ), EVISTA (View Evista Review and Evista Label ), LASIX (View Lasix Review and Lasix Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CALCIUM (View Calcium Review and Calcium Label ). Patient was hospitalized and became disabled.

6686039-4 | Bronchitis Chronic, Condition Aggravated, Pneumonia
Patient was taking Brovana (View Usage). Patient had the following side effects: bronchitis chronic, condition aggravated, pneumonia (What is pneumonia?) on Mar 31, 2010 from UNITED STATES Additional patient health information: Male patient , 83 years of age, was diagnosed with bronchitis chronic and. Brovana dosage: 15 Ug/2ml;bid;inhalation. During the same period patient was treated with BUDESONIDE (View Budesonide Review and Budesonide Label ). Patient was hospitalized.

6646623-0 |
Adverse event was reported on Mar 03, 2010 by a Male patient taking Brovana (View Usage) (Dosage: 14 Ug/2ml;bid;inhalation) was diagnosed with dyspnoea, lung neoplasm malignant and. Location: UNITED STATES , 75 years of age, . During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), COZAAR (View Cozaar Review and Cozaar Label ), NORVASC (View Norvasc Review and Norvasc Label ), COREG (View Coreg Review and Coreg Label ), LASIX (View Lasix Review and Lasix Label ), EXELON (View Exelon Review and Exelon Label ), ZOLOFT /01011402/ (View Zoloft /01011402/ Review and Zoloft /01011402/ Label ).

6619507-1 | Anxiety, Asthma, Blood Potassium Decreased, Blood Pressure Fluctuation, Cholelithiasis, Chronic Obstructive Pulmonary Disease, Colitis, Computerised Tomogram Thorax Abnormal, Condition Aggravated
on Feb 18, 2010 Female patient from UNITED STATES , 68 years of age, weighting 155.9 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Brovana (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), asthma (What is asthma?), blood potassium decreased, blood pressure fluctuation, cholelithiasis, chronic obstructive pulmonary disease, colitis, computerised tomogram thorax abnormal, condition aggravated. Brovana dosage: 15 Ug/2ml;bid; Inhalation. During the same period patient was treated with XOPENEX (1.25 Mg/3ml; Tid; Inhalation) (View Xopenex Review and Xopenex Label ), ACTONEL (View Actonel Review and Actonel Label ), NORVASC (View Norvasc Review and Norvasc Label ), NEXIUM (View Nexium Review and Nexium Label ), SINGULAIR (View Singulair Review and Singulair Label ). Patient was hospitalized.


6575927-5 | Atrial Fibrillation, Tobacco User
on Jan 29, 2010 Male patient from UNITED STATES , 70 years of age, was diagnosed with chronic obstructive pulmonary disease, emphysema and was treated with Brovana (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), tobacco user. Brovana dosage: . During the same period patient was treated with DUONEB (View Duoneb Review and Duoneb Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), ANABOLIC STEROIDS (View Anabolic Steroids Review and Anabolic Steroids Label ), CLARITIN /00917501/ (View Claritin /00917501/ Review and Claritin /00917501/ Label ), ALAVERT (View Alavert Review and Alavert Label ), FLONASE (View Flonase Review and Flonase Label ). Patient was hospitalized.

6571198-4 | Anxiety, Blood Glucose Increased, Blood Potassium Decreased, Chronic Obstructive Pulmonary Disease, Condition Aggravated, Diarrhoea, Dyskinesia Oesophageal, Epistaxis, Herpes Zoster
Patient was taking Brovana (View Usage). After Brovana was administered, patient had the following side effects: anxiety (What is anxiety?), blood glucose increased, blood potassium decreased, chronic obstructive pulmonary disease, condition aggravated, diarrhoea, dyskinesia oesophageal, epistaxis, herpes zoster on Jan 18, 2010 from UNITED STATES Additional patient health information: Female patient , 68 years of age, weighting 155.9 lb, was diagnosed with chronic obstructive pulmonary disease and. Brovana dosage: 15 Ug/2ml;bid;inhalation. During the same period patient was treated with XOPENEX (1.25 Mg/3ml;tid;inhalation; 1.25 Mg/3ml;qh4;inhalation; 1.25 Mg/3ml;tid;inhalation) (View Xopenex Review and Xopenex Label ), ACTONEL (View Actonel Review and Actonel Label ), NEXIUM (View Nexium Review and Nexium Label ), NORVASC (View Norvasc Review and Norvasc Label ), SINGULAIR (View Singulair Review and Singulair Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ). Patient was hospitalized.

6542786-6 | Ankle Fracture, Cataract, Dyspnoea, Fall, Gastrointestinal Infection, Hypotension, Maculopathy, Pain
Adverse event was reported on Jan 04, 2010 by a Female patient taking Brovana (View Usage) (Dosage: 15 Ug/2ml; Bid; Inhalation) was diagnosed with chronic obstructive pulmonary disease and. Location: UNITED STATES , 83 years of age, Patient experienced the following unwanted or unexpected effects: ankle fracture, cataract (What is cataract?), dyspnoea, fall (What is fall?), gastrointestinal infection, hypotension, maculopathy, pain (What is pain?). During the same period patient was treated with ZOCOR (View Zocor Review and Zocor Label ), CELEXA (View Celexa Review and Celexa Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6397913-0 | Chronic Obstructive Pulmonary Disease, Infection
on Sep 23, 2009 Female patient from UNITED STATES , 84 years of age, weighting 119.9 lb, was diagnosed with chronic obstructive pulmonary disease, emphysema and was treated with Brovana (View Usage). Patient had the following side effects: chronic obstructive pulmonary disease, infection (What is infection?). Brovana dosage: 15 Ug/2ml; Bid; Inhalation. During the same period patient was treated with SPIRIVA (View Spiriva Review and Spiriva Label ), SINGULAIR (View Singulair Review and Singulair Label ), ATROVENT (View Atrovent Review and Atrovent Label ), VITAMINS (View Vitamins Review and Vitamins Label ), XOPENEX (View Xopenex Review and Xopenex Label ). Patient was hospitalized.

6387442-2 | Diverticulum, Dyspnoea, Escherichia Bacteraemia, Headache, Interstitial Lung Disease, Pneumonia
on Sep 21, 2009 Male patient from UNITED STATES , 60 years of age, weighting 176.4 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Brovana (View Usage). After Brovana was administered, patient had the following side effects: diverticulum, dyspnoea, escherichia bacteraemia, headache (What is headache?), interstitial lung disease, pneumonia (What is pneumonia?). Brovana dosage: 15 Ug/2ml;bid;inhalation ; 15 Ug/2ml;bid;inhalation. During the same period patient was treated with ALVESCO INHALATION (View Alvesco Inhalation Review and Alvesco Inhalation Label ), AEROSOL (View Aerosol Review and Aerosol Label ), PREV MEDS (View Prev Meds Review and Prev Meds Label ). Patient was hospitalized.

6378633-5 | Intestinal Obstruction
Patient was taking Brovana (View Usage). Patient experienced the following unwanted or unexpected effects: intestinal obstruction on Sep 08, 2009 from UNITED STATES Additional patient health information: Female patient , 74 years of age, weighting 132.9 lb, was diagnosed with chronic obstructive pulmonary disease and. Brovana dosage: 15 Ug/2ml; Bid; Inhalation. During the same period patient was treated with SPIRIVA (View Spiriva Review and Spiriva Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

6299132-5 | Chronic Obstructive Pulmonary Disease, Headache, Hypotension, Loss Of Consciousness, Pain, Pleural Effusion
Adverse event was reported on Jul 21, 2009 by a Male patient taking Brovana (View Usage) (Dosage: 15 Ug/2ml; Bid; Inhalation) was diagnosed with chronic obstructive pulmonary disease, asthma (What is asthma?), cardiac failure congestive, hypertension and. Location: UNITED STATES , 70 years of age, weighting 200.0 lb, Patient had the following side effects: chronic obstructive pulmonary disease, headache (What is headache?), hypotension, loss of consciousness, pain (What is pain?), pleural effusion. During the same period patient was treated with XOPENEX (1.25 Mg/3ml; Prn; Inhalation) (View Xopenex Review and Xopenex Label ), LASIX (40 Mg; Qd; Oral, 20 Mg; Qod; Oral) (View Lasix Review and Lasix Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), PULMICORT 100 (View Pulmicort-100 Review and Pulmicort-100 Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), PROTONIX (View Protonix Review and Protonix Label ), SINGULAIR (View Singulair Review and Singulair Label ). Patient was hospitalized.

6270883-1 | Amnesia, Convulsion, Insomnia, Treatment Noncompliance
on Jul 01, 2009 Female patient from UNITED STATES , 43 years of age, was diagnosed with asthma (What is asthma?) and was treated with Brovana (View Usage). After Brovana was administered, patient had the following side effects: amnesia, convulsion, insomnia, treatment noncompliance. Brovana dosage: 15 Ug/2ml; Prn; Inhalation. During the same period patient was treated with PULMICORT 100 (; Bid;) (View Pulmicort-100 Review and Pulmicort-100 Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), REGLAN (View Reglan Review and Reglan Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), VICODIN (View Vicodin Review and Vicodin Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ).

6170884-8 | Heart Rate Irregular
on Apr 13, 2009 Female patient from UNITED STATES , 66 years of age, was treated with Brovana (View Usage). Patient experienced the following unwanted or unexpected effects: heart rate irregular. Brovana dosage: 15 Ug/2ml; Bid; Inhalation. During the same period patient was treated with XOPENEX (0.63 Mg/3ml; Prn; Inhalation) (View Xopenex Review and Xopenex Label ), BUDESONIDE (Inhalation) (View Budesonide Review and Budesonide Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), WARFARIN (View Warfarin Review and Warfarin Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), VENTOLIN HFA (View Ventolin Hfa Review and Ventolin Hfa Label ), METHIMAZOLE (View Methimazole Review and Methimazole Label ). Patient was hospitalized.

6147214-0 | Dehydration, Dizziness, Gastroenteritis, Lung Infection, Tremor, Weight Decreased
Patient was taking Brovana (View Usage). Patient had the following side effects: dehydration, dizziness (What is dizziness?), gastroenteritis (What is gastroenteritis?), lung infection, tremor, weight decreased on Mar 26, 2009 from UNITED STATES Additional patient health information: Female patient , 83 years of age, weighting 116.0 lb, was diagnosed with chronic obstructive pulmonary disease and. Brovana dosage: 15 Ug/2ml; Bid; Inhalation. During the same period patient was treated with PULMICORT 100 (View Pulmicort-100 Review and Pulmicort-100 Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ). Patient was hospitalized.

6124417-2 | Condition Aggravated, Eructation, Heart Rate Increased, Insomnia, Respiratory Disorder, Sarcoma Of Skin
Adverse event was reported on Mar 02, 2009 by a Female patient taking Brovana (View Usage) (Dosage: 15 Ug/2ml; Bid; Inhalation; 15 Ug/2ml; Qd;inhalation) was diagnosed with chronic obstructive pulmonary disease and. Location: UNITED STATES , 68 years of age, weighting 132.1 lb, After Brovana was administered, patient had the following side effects: condition aggravated, eructation, heart rate increased, insomnia, respiratory disorder, sarcoma of skin. During the same period patient was treated with XOPENEX (View Xopenex Review and Xopenex Label ), HYDROXYCHLOROQUINE (View Hydroxychloroquine Review and Hydroxychloroquine Label ), COMBIVENT /01261001/ (View Combivent /01261001/ Review and Combivent /01261001/ Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), BONIVA (View Boniva Review and Boniva Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6028081-2 | Convulsion, Loss Of Consciousness
on Dec 23, 2008 Female patient from UNITED STATES , 67 years of age, was diagnosed with asthma (What is asthma?) and was treated with Brovana (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, loss of consciousness. Brovana dosage: 15 Ug/2ml; Bid; Inhalation. During the same period patient was treated with PULMICORT 100 (Bid; Inhalation) (View Pulmicort-100 Review and Pulmicort-100 Label ), LIPITOR (CON.) (View Lipitor (con.) Review and Lipitor (con.) Label ), ACIPHEX (CON.) (View Aciphex (con.) Review and Aciphex (con.) Label ), ZOLOFT /01011402/ (CON.) (View Zoloft /01011402/ (con.) Review and Zoloft /01011402/ (con.) Label ), VITAMINS (CON.) (View Vitamins (con.) Review and Vitamins (con.) Label ), PREV MEDS (View Prev Meds Review and Prev Meds Label ). Patient was hospitalized.

5950919-5 | Condition Aggravated, Dyspnoea, Nervousness, Pulmonary Embolism
on Oct 27, 2008 Male patient from UNITED STATES , 77 years of age, was diagnosed with pulmonary fibrosis (What is pulmonary fibrosis?) and was treated with Brovana (View Usage). Patient had the following side effects: condition aggravated, dyspnoea, nervousness, pulmonary embolism (What is pulmonary embolism?). Brovana dosage: 15 Ug/2ml;bid;inhalation. During the same period patient was treated with PULMICORT 100 (View Pulmicort-100 Review and Pulmicort-100 Label ), COUMADIN (View Coumadin Review and Coumadin Label ), DUONEB (View Duoneb Review and Duoneb Label ). Patient was hospitalized.

5919977-8 | Chest Discomfort, Intestinal Obstruction, Nervousness, Tremor
Patient was taking Brovana (View Usage). After Brovana was administered, patient had the following side effects: chest discomfort, intestinal obstruction, nervousness, tremor on Sep 29, 2008 from UNITED STATES Additional patient health information: Female patient , 68 years of age, was diagnosed with emphysema and. Brovana dosage: 15 Ug / 2ml; Bid;inhalation. During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), DUONEB (View Duoneb Review and Duoneb Label ), LIPITOR (View Lipitor Review and Lipitor Label ), MIRAPEX (View Mirapex Review and Mirapex Label ), MUCINEX (View Mucinex Review and Mucinex Label ), SINGULAIR (View Singulair Review and Singulair Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ). Patient was hospitalized.

5869862-5 | Blood Pressure Increased, Chronic Obstructive Pulmonary Disease, Condition Aggravated, Heart Rate Increased, Stomatitis
Adverse event was reported on Aug 18, 2008 by a Female patient taking Brovana (View Usage) (Dosage: 15 Ug/2ml;bid;inhalation) was diagnosed with chronic obstructive pulmonary disease and. Location: UNITED STATES , 79 years of age, weighting 120.2 lb, Patient experienced the following unwanted or unexpected effects: blood pressure increased, chronic obstructive pulmonary disease, condition aggravated, heart rate increased, stomatitis. During the same period patient was treated with XOPENEX (0.63 Mg/3ml;bid;inhalation) (View Xopenex Review and Xopenex Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), CARTIA XT (View Cartia Xt Review and Cartia Xt Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

5869860-1 | Atrial Fibrillation, Condition Aggravated
on Aug 26, 2008 Female patient from UNITED STATES , 72 years of age, weighting 159.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Brovana (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), condition aggravated. Brovana dosage: 15 Ug/2ml; Bid; Inhalation. During the same period patient was treated with FISH OIL (View Fish Oil Review and Fish Oil Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), XOPENEX HFA INHALATION (View Xopenex Hfa Inhalation Review and Xopenex Hfa Inhalation Label ), AEROSOL (View Aerosol Review and Aerosol Label ), ASMANEX TWISTHALER (View Asmanex Twisthaler Review and Asmanex Twisthaler Label ), ZOCOR (View Zocor Review and Zocor Label ), OXYGEN (View Oxygen Review and Oxygen Label ), COMBIVENT /01261001/ (View Combivent /01261001/ Review and Combivent /01261001/ Label ). Patient was hospitalized.

5797434-X | Back Pain, Fall, Hip Fracture, Pain In Extremity
on Jun 16, 2008 Female patient from UNITED STATES , weighting 110.2 lb, was diagnosed with emphysema and was treated with Brovana (View Usage). After Brovana was administered, patient had the following side effects: back pain (What is back pain?), fall (What is fall?), hip fracture, pain in extremity. Brovana dosage: 15 Ug/2ml; Bid; Inhalation, 15 Ug/2ml; Tid; Inhalation. During the same period patient was treated with PULMICORT 100 (View Pulmicort-100 Review and Pulmicort-100 Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

5741255-0 | Abdominal Pain, Asthenia, Ataxia, Atrial Fibrillation, Balance Disorder, Bronchitis, Cerebrovascular Accident, Chronic Obstructive Pulmonary Disease, Condition Aggravated
Patient was taking Brovana (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), asthenia, ataxia (What is ataxia?), atrial fibrillation (What is atrial fibrillation?), balance disorder, bronchitis (What is bronchitis?), cerebrovascular accident, chronic obstructive pulmonary disease, condition aggravated on Apr 30, 2008 from UNITED STATES Additional patient health information: Female patient , 77 years of age, weighting 121.0 lb, was diagnosed with chronic obstructive pulmonary disease and. Brovana dosage: 15 Ug/2ml; Bid; Inhalation. During the same period patient was treated with PREVACID (View Prevacid Review and Prevacid Label ), CARTIA XT /00489701/ (View Cartia Xt /00489701/ Review and Cartia Xt /00489701/ Label ), LASIX (View Lasix Review and Lasix Label ), MUCINEX (View Mucinex Review and Mucinex Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), VARENICLINE (View Varenicline Review and Varenicline Label ), ENULOSE (View Enulose Review and Enulose Label ). Patient was hospitalized.

5738681-2 | Asthma, Body Temperature Decreased, Ear Pain, Insomnia, Malaise, Restlessness, Treatment Noncompliance
Adverse event was reported on May 01, 2008 by a Female patient taking Brovana (View Usage) (Dosage: 15 Ug; Inhalation) was diagnosed with chronic obstructive pulmonary disease and. Location: UNITED STATES , 85 years of age, weighting 132.0 lb, Patient had the following side effects: asthma (What is asthma?), body temperature decreased, ear pain, insomnia, malaise, restlessness, treatment noncompliance. During the same period patient was treated with XOPENEX (Q4h; Inhalation) (View Xopenex Review and Xopenex Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), KENALOG (View Kenalog Review and Kenalog Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), OXYGEN (View Oxygen Review and Oxygen Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

5713827-0 | Insomnia, Refusal Of Treatment By Patient, Treatment Noncompliance, Wheezing
on Apr 10, 2008 Female patient from UNITED STATES , 82 years of age, was treated with Brovana (View Usage). After Brovana was administered, patient had the following side effects: insomnia, refusal of treatment by patient, treatment noncompliance, wheezing. Brovana dosage: Inhalation. During the same period patient was treated with XOPENEX (Q4h, Inhalation) (View Xopenex Review and Xopenex Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), KENALOG (View Kenalog Review and Kenalog Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), OXYGEN (View Oxygen Review and Oxygen Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), ADVAIR HFA (View Advair Hfa Review and Advair Hfa Label ).

5699804-7 | Asthma, Bronchospasm, Chest Discomfort, Dyspnoea, Hypersensitivity, Hypoxia, Respiratory Distress
on Mar 27, 2008 Male patient from UNITED STATES , 62 years of age, weighting 180.0 lb, was diagnosed with chronic obstructive pulmonary disease, asthma (What is asthma?) and was treated with Brovana (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), bronchospasm, chest discomfort, dyspnoea, hypersensitivity, hypoxia, respiratory distress. Brovana dosage: 15 Ug/2ml; 1x; Inhalation. During the same period patient was treated with XOPENEX (0.63 Mg/3ml; Prn; Inhalation) (View Xopenex Review and Xopenex Label ), COMBIVENT /01033501/ (View Combivent /01033501/ Review and Combivent /01033501/ Label ), PAXIL (View Paxil Review and Paxil Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), AMBIEN (View Ambien Review and Ambien Label ), SPIRIVA (View Spiriva Review and Spiriva Label ). Patient was hospitalized.

5699328-7 | Dizziness, Dry Mouth, Dyspnoea, Foaming At Mouth, Haemoptysis, Haemorrhage, Headache, Hypotension
Patient was taking Brovana (View Usage). Patient had the following side effects: dizziness (What is dizziness?), dry mouth, dyspnoea, foaming at mouth, haemoptysis, haemorrhage, headache (What is headache?), hypotension on Mar 24, 2008 from UNITED STATES Additional patient health information: Male patient , 72 years of age, weighting 153.0 lb, was diagnosed with chronic obstructive pulmonary disease and. Brovana dosage: 15 Ug/2ml; Bid; Inhalation. During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LEXAPRO (View Lexapro Review and Lexapro Label ). Patient was hospitalized.

5699327-5 | Asthma, Bronchospasm, Burning Sensation, Chest Discomfort, Chest Pain, Condition Aggravated, Dyspnoea, Hypersensitivity, Respiratory Distress
Adverse event was reported on Mar 27, 2008 by a Male patient taking Brovana (View Usage) (Dosage: 15 Ug/2ml;1x;inhalation) was diagnosed with chronic obstructive pulmonary disease, asthma (What is asthma?) and. Location: UNITED STATES , 62 years of age, weighting 180.0 lb, After Brovana was administered, patient had the following side effects: asthma (What is asthma?), bronchospasm, burning sensation, chest discomfort, chest pain (What is chest pain?), condition aggravated, dyspnoea, hypersensitivity, respiratory distress. During the same period patient was treated with XOPENEX (0.63 Mg/3ml; Prn; Inhalation) (View Xopenex Review and Xopenex Label ), COMBIVENT (View Combivent Review and Combivent Label ), PAXIL (View Paxil Review and Paxil Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), AMBIEN (View Ambien Review and Ambien Label ), SPIRIVA (View Spiriva Review and Spiriva Label ). Patient was hospitalized.

5689909-9 | Cardiac Failure Congestive, Chronic Obstructive Pulmonary Disease
on Mar 31, 2008 Female patient from UNITED STATES , weighting 137.3 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Brovana (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, chronic obstructive pulmonary disease. Brovana dosage: .

5678979-X | Asthma, Chest Discomfort, Dyspnoea, Palpitations
on Mar 06, 2008 Female patient from UNITED STATES , 69 years of age, weighting 196.0 lb, was diagnosed with asthma (What is asthma?), chronic obstructive pulmonary disease and was treated with Brovana (View Usage). Patient had the following side effects: asthma (What is asthma?), chest discomfort, dyspnoea, palpitations. Brovana dosage: 15 Ug/2ml;bid;inhalation. During the same period patient was treated with PRILOSEC (View Prilosec Review and Prilosec Label ), PYRIDOSTIGMINE BROMIDE (View Pyridostigmine Bromide Review and Pyridostigmine Bromide Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), NEURONTIN (View Neurontin Review and Neurontin Label ). Patient was hospitalized.

5631513-2 |
Patient was taking Brovana (View Usage). on Feb 01, 2008 from UNITED STATES Additional patient health information: Female patient , 82 years of age, . Brovana dosage: Inhalation. During the same period patient was treated with XOPENEX (;q4h;inhalation) (View Xopenex Review and Xopenex Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ).

5619302-6 | Chronic Obstructive Pulmonary Disease, Condition Aggravated, Malaise
Adverse event was reported on Jan 23, 2008 by a Male patient taking Brovana (View Usage) (Dosage: 15 Ug/2ml;bid;inhalation) was diagnosed with chronic obstructive pulmonary disease and. Location: UNITED STATES , 63 years of age, Patient experienced the following unwanted or unexpected effects: chronic obstructive pulmonary disease, condition aggravated, malaise. During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), ATROVENT (View Atrovent Review and Atrovent Label ), PRENISONE (View Prenisone Review and Prenisone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), HYDROCODONE BITARTRATE (View Hydrocodone Bitartrate Review and Hydrocodone Bitartrate Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ). Patient was hospitalized.

5567641-X | Asthma, Chronic Obstructive Pulmonary Disease, Condition Aggravated
on Nov 30, 2007 Female patient from UNITED STATES , 73 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Brovana (View Usage). Patient had the following side effects: asthma (What is asthma?), chronic obstructive pulmonary disease, condition aggravated. Brovana dosage: 15 Ug/2ml; Q12h; Inhalation. During the same period patient was treated with XOPENEX (1.25 Mg/3ml; Q6h; Inhalation, 1.25 Mg/3ml; Q3h; Inhalation) (View Xopenex Review and Xopenex Label ), NAMENDA (View Namenda Review and Namenda Label ), ALBUTEROL SULFATE (View Albuterol Sulfate Review and Albuterol Sulfate Label ), TIOTROPIUM BROMIDE (View Tiotropium Bromide Review and Tiotropium Bromide Label ), CARBIDOPA (View Carbidopa Review and Carbidopa Label ), SINGULAIR (View Singulair Review and Singulair Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), JENUVIA (View Jenuvia Review and Jenuvia Label ). Patient was hospitalized.

5566491-8 | Chronic Obstructive Pulmonary Disease, Dyspnoea, Faecal Incontinence, Hiatus Hernia, Urinary Incontinence, Wheezing
on Nov 30, 2007 Female patient from UNITED STATES , 73 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Brovana (View Usage). After Brovana was administered, patient had the following side effects: chronic obstructive pulmonary disease, dyspnoea, faecal incontinence, hiatus hernia, urinary incontinence (What is urinary incontinence?), wheezing. Brovana dosage: 15ug/2ml;q12h; Inhalation. During the same period patient was treated with XOPENEX (1.25 Mg/3ml; Q6h; Inhalation ; 1.25 Mg/3ml;23h; Inhalation) (View Xopenex Review and Xopenex Label ), NAMENDA (View Namenda Review and Namenda Label ), ALBUTEROL SULFATE (View Albuterol Sulfate Review and Albuterol Sulfate Label ), TIOTROPIUM BROMIDE (View Tiotropium Bromide Review and Tiotropium Bromide Label ), CARBIDOPA (View Carbidopa Review and Carbidopa Label ), SINGULAIR (View Singulair Review and Singulair Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), JANUVIA (View Januvia Review and Januvia Label ). Patient was hospitalized.

5525746-3 | Coronary Artery Disease, Coronary Artery Occlusion, Myocardial Infarction
Patient was taking Brovana (View Usage). Patient experienced the following unwanted or unexpected effects: coronary artery disease (What is coronary artery disease?), coronary artery occlusion, myocardial infarction on Nov 06, 2007 from UNITED STATES Additional patient health information: Male patient , 76 years of age, weighting 196.0 lb, was diagnosed with chronic obstructive pulmonary disease and. Brovana dosage: 15 Ug/2ml; Inhalation. During the same period patient was treated with XOPENEX (Inhalation) (View Xopenex Review and Xopenex Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), SINGULAIR (View Singulair Review and Singulair Label ), MOBIC (View Mobic Review and Mobic Label ), CYMBALATA (View Cymbalata Review and Cymbalata Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ). Patient was hospitalized.

5517814-7 | Asthenia, Chronic Obstructive Pulmonary Disease, Dry Mouth, Malaise, Nervousness, Pharyngolaryngeal Pain, Pneumonia, Refusal Of Treatment By Patient, Respiratory Failure
Adverse event was reported on Nov 01, 2007 by a Female patient taking Brovana (View Usage) (Dosage: 15 Ug/2ml;bid;inhalation) was diagnosed with chronic obstructive pulmonary disease and. Location: UNITED STATES , 65 years of age, weighting 120.0 lb, Patient had the following side effects: asthenia, chronic obstructive pulmonary disease, dry mouth, malaise, nervousness, pharyngolaryngeal pain, pneumonia (What is pneumonia?), refusal of treatment by patient, respiratory failure. During the same period patient was treated with OXYGEN (View Oxygen Review and Oxygen Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), TIOTROPIUM (View Tiotropium Review and Tiotropium Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), DUONEB (View Duoneb Review and Duoneb Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ), FORMOTEROL FUMARATE (View Formoterol Fumarate Review and Formoterol Fumarate Label ). Patient was hospitalized.

5517813-5 | Asthma, Blood Iron Decreased, Condition Aggravated, Haemorrhoidal Haemorrhage, Infection
on Nov 05, 2007 Female patient from UNITED STATES , 73 years of age, was diagnosed with chronic obstructive pulmonary disease, emphysema and was treated with Brovana (View Usage). After Brovana was administered, patient had the following side effects: asthma (What is asthma?), blood iron decreased, condition aggravated, haemorrhoidal haemorrhage, infection (What is infection?). Brovana dosage: 15 Ug/2ml;bid;inhalation. During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), EFFEXOR (View Effexor Review and Effexor Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), OXYGEN (View Oxygen Review and Oxygen Label ), TIOTROPIUM BROMIDE (View Tiotropium Bromide Review and Tiotropium Bromide Label ). Patient was hospitalized.

5517709-9 | Dyspnoea
on Nov 06, 2007 Female patient from UNITED STATES , 71 years of age, was treated with Brovana (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea. Brovana dosage: 15 Ug/2ml; Bid; Inhalation. During the same period patient was treated with ANALGESICS (View Analgesics Review and Analgesics Label ). Patient was hospitalized.

5513857-8 | Dyspnoea
Patient was taking Brovana (View Usage). Patient had the following side effects: dyspnoea on Sep 10, 2007 from UNITED STATES Additional patient health information: Male patient , 72 years of age, was diagnosed with chronic obstructive pulmonary disease and. Brovana dosage: 15 Ug/2ml;bid;inhalation. During the same period patient was treated with OXYGEN (View Oxygen Review and Oxygen Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), FORMOTEROL FUMARATE (View Formoterol Fumarate Review and Formoterol Fumarate Label ), XOPENEX (View Xopenex Review and Xopenex Label ). Patient was hospitalized.

5500224-6 | Alveolitis, Atrial Conduction Time Prolongation, Bacterial Infection, Blood Creatine Phosphokinase Mb Increased, Blood Pressure Decreased, Bronchiectasis, Bundle Branch Block Right, Cardiac Arrest, Cardiomegaly
Adverse event was reported on Oct 11, 2007 by a Male patient taking Brovana (View Usage) (Dosage: 15 Ug/2ml;bid; Inhalation) was diagnosed with chronic obstructive pulmonary disease and. Location: UNITED STATES , 65 years of age, weighting 150.0 lb, After Brovana was administered, patient had the following side effects: alveolitis, atrial conduction time prolongation, bacterial infection (What is bacterial infection?), blood creatine phosphokinase mb increased, blood pressure decreased, bronchiectasis, bundle branch block right, cardiac arrest (What is cardiac arrest?), cardiomegaly. During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), XOPENEX (View Xopenex Review and Xopenex Label ), AVELOX (View Avelox Review and Avelox Label ), BRETHINE (View Brethine Review and Brethine Label ), DUONEB (View Duoneb Review and Duoneb Label ), ALBUTEROL SULFATE W/IPRATROPIUM BROMIDE (View Albuterol Sulfate W/ipratropium Bromide Review and Albuterol Sulfate W/ipratropium Bromide Label ), FLOVENT (View Flovent Review and Flovent Label ). Patient was hospitalized.

5481611-1 | Cardiac Arrest, Chronic Obstructive Pulmonary Disease, Condition Aggravated, Oedema Peripheral
on Sep 20, 2007 Female patient from UNITED STATES , 81 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with Brovana (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), chronic obstructive pulmonary disease, condition aggravated, oedema peripheral. Brovana dosage: Bid; Inhalation. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), QVAR 40 (View Qvar 40 Review and Qvar 40 Label ), OXYGEN (View Oxygen Review and Oxygen Label ).

5444083-9 | Breath Sounds Abnormal, Bundle Branch Block, Chest Pain, Heart Rate Increased, No Therapeutic Response, Pneumonitis, Sinus Tachycardia, Stenotrophomonas Infection, Weight Decreased
on Aug 24, 2007 Female patient from UNITED STATES , 57 years of age, weighting 263.0 lb, was diagnosed with asthma (What is asthma?), chronic obstructive pulmonary disease and was treated with Brovana (View Usage). Patient had the following side effects: breath sounds abnormal, bundle branch block, chest pain (What is chest pain?), heart rate increased, no therapeutic response, pneumonitis, sinus tachycardia, stenotrophomonas infection, weight decreased. Brovana dosage: 15 Ug; Bid; Inhalation. During the same period patient was treated with AVELOX (View Avelox Review and Avelox Label ), DUONEB (View Duoneb Review and Duoneb Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ), OXYGEN (View Oxygen Review and Oxygen Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ). Patient was hospitalized.

5442633-X | Bronchiectasis, Cardiac Arrest, Chronic Obstructive Pulmonary Disease, Clostridium Difficile Colitis, Fungal Infection, Hyperkalaemia, Lung Infection, Lung Infiltration, Renal Failure Acute
Patient was taking Brovana (View Usage). After Brovana was administered, patient had the following side effects: bronchiectasis, cardiac arrest (What is cardiac arrest?), chronic obstructive pulmonary disease, clostridium difficile colitis, fungal infection (What is fungal infection?), hyperkalaemia, lung infection, lung infiltration, renal failure acute on Aug 16, 2007 from UNITED STATES Additional patient health information: Male patient , 65 years of age, was diagnosed with chronic obstructive pulmonary disease and. Brovana dosage: 15 Ug/2ml; Bid; Inhalation. During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), XOPENEX (View Xopenex Review and Xopenex Label ). Patient was hospitalized.

5431425-3 | Emphysema, Hyperventilation, Respiratory Tract Infection
Adverse event was reported on Aug 16, 2007 by a Male patient taking Brovana (View Usage) (Dosage: 15 Ug/2ml; Inhalation) was diagnosed with chronic obstructive pulmonary disease and. Location: UNITED STATES , 84 years of age, weighting 140.0 lb, Patient experienced the following unwanted or unexpected effects: emphysema, hyperventilation, respiratory tract infection. During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), HYZAAR (View Hyzaar Review and Hyzaar Label ), VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ), TIOTROPIUM BROMIDE (View Tiotropium Bromide Review and Tiotropium Bromide Label ), OXYGEN (View Oxygen Review and Oxygen Label ).

5423068-2 |
on Aug 06, 2007 Female patient from UNITED STATES , 57 years of age, was diagnosed with asthma (What is asthma?), chronic obstructive pulmonary disease and was treated with Brovana (View Usage). . Brovana dosage: 15 Ug; Bid; Inhalation. During the same period patient was treated with AVELOX (View Avelox Review and Avelox Label ), DUONEB (View Duoneb Review and Duoneb Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ), OXYGEN (View Oxygen Review and Oxygen Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ). Patient was hospitalized.

5388800-5 | Unresponsive To Stimuli
on Jun 27, 2007 Male patient from UNITED STATES , 83 years of age, was diagnosed with wheezing and was treated with Brovana (View Usage). After Brovana was administered, patient had the following side effects: unresponsive to stimuli. Brovana dosage: Inhalation. During the same period patient was treated with ALBUTEROL SULFATE W/ IPRATROPIUM BROMIDE (View Albuterol Sulfate W/ Ipratropium Bromide Review and Albuterol Sulfate W/ Ipratropium Bromide Label ).